Insider Selling: Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Major Shareholder Sells $884,511.60 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) major shareholder Morningside Venture Investment sold 29,048 shares of Amylyx Pharmaceuticals stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $30.45, for a total value of $884,511.60. Following the completion of the transaction, the insider now directly owns […]

Related Keywords

Canada ,United States ,China ,America , ,Nasdaq ,Amylyx Pharmaceuticals Price Performance ,Life Insurance Co ,Amylyx Pharmaceuticals ,Quarter For Amylyx Pharmaceuticals ,News Ratings For Amylyx Pharmaceuticals Daily ,Hedge Funds Weigh In On Amylyx Pharmaceuticals ,Citigroup ,Amylyx Pharmaceuticals Inc ,High Net Worth Advisory Group ,China Universal Asset Management Co ,Goldman Sachs Group ,Loring Wolcott Coolidge Fiduciary Advisors ,Royal Bank ,Get Rating ,Morningside Venture Investment ,Venture Investment ,Universal Asset Management ,Coolidge Fiduciary Advisors ,Net Worth Advisory Group ,Amylyx Pharmaceuticals Daily ,Nasdaq Amlx ,Amlx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,